Emergence of antibiotic-resistant bacteria in patients with Fournier gangrene

Surg Infect (Larchmt). 2015 Apr;16(2):165-8. doi: 10.1089/sur.2013.118. Epub 2014 Sep 12.

Abstract

Background: This study was conducted to investigate the bacteriology and associated patterns of antibiotic resistance Fournier gangrene.

Methods: Patients with Fournier's gangrene from 2008 to 2012 were identified from the computerized database in a medical center in southern Taiwan. The medical records of all patients with Fournier's gangrene were reviewed retrospectively.

Results: There were 61 microorganisms, including 60 bacteria and one Candida spp, isolated from clinical wound specimens from 32 patients. The most common isolates obtained were Streptococcus spp. (n=12), Peptoniphilus spp. (n=8), Staphylococcus aureus (n=7), Escherichia coli (n=7), and Klebsiella pneumoniae (n=7). Among 21 strains of gram-negative bacilli, five (23.8%) were resistant to fluoroquinolones, and three isolates were resistant to ceftriaxone. Two E. coli strains produced extended-spectrum beta-lactamase. Four of the seven S. aureus isolates were methicillin-resistant. Among 15 anaerobic isolates, nine (60%) were resistant to penicillin, and eight (53.3%) were resistant to clindamycin. Four (26.7%) isolates were resistant to metronidazole. The only independent risk factor associated with mortality was inappropriate initial antibiotic treatment (p=0.021).

Conclusion: Antibiotic-resistant bacteria are emerging in the clinical setting of Fournier gangrene. Clinicians should use broad-spectrum antibiotics initially to cover possible antibiotic-resistant bacteria.

MeSH terms

  • Aged
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Bacteria / drug effects*
  • Candida / drug effects
  • Drug Resistance, Bacterial*
  • Female
  • Fournier Gangrene / drug therapy
  • Fournier Gangrene / epidemiology*
  • Fournier Gangrene / microbiology*
  • Fournier Gangrene / mortality
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Taiwan / epidemiology
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents